These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


339 related items for PubMed ID: 23801676

  • 1. PET imaging of high-affinity α4β2 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kinetics.
    Wong DF, Kuwabara H, Kim J, Brasic JR, Chamroonrat W, Gao Y, Valentine H, Willis W, Mathur A, McCaul ME, Wand G, Gean EG, Dannals RF, Horti AG.
    J Nucl Med; 2013 Aug; 54(8):1308-14. PubMed ID: 23801676
    [Abstract] [Full Text] [Related]

  • 2. PET Imaging of nicotinic acetylcholine receptors in baboons with 18F-AZAN, a radioligand with improved brain kinetics.
    Kuwabara H, Wong DF, Gao Y, Valentine H, Holt DP, Ravert HT, Dannals RF, Horti AG.
    J Nucl Med; 2012 Jan; 53(1):121-9. PubMed ID: 22173841
    [Abstract] [Full Text] [Related]

  • 3. Imaging α4β2 Nicotinic Acetylcholine Receptors (nAChRs) in Baboons with [18F]XTRA, a Radioligand with Improved Specific Binding in Extra-Thalamic Regions.
    Kuwabara H, Gao Y, Stabin M, Coughlin J, Nimmagadda S, Dannals RF, Pomper MG, Horti AG.
    Mol Imaging Biol; 2017 Apr; 19(2):280-288. PubMed ID: 27562686
    [Abstract] [Full Text] [Related]

  • 4. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
    Sabri O, Becker GA, Meyer PM, Hesse S, Wilke S, Graef S, Patt M, Luthardt J, Wagenknecht G, Hoepping A, Smits R, Franke A, Sattler B, Habermann B, Neuhaus P, Fischer S, Tiepolt S, Deuther-Conrad W, Barthel H, Schönknecht P, Brust P.
    Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
    [Abstract] [Full Text] [Related]

  • 5. Discovery of (-)-7-methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane, a radiolabeled antagonist for cerebral nicotinic acetylcholine receptor (alpha4beta2-nAChR) with optimal positron emission tomography imaging properties.
    Gao Y, Kuwabara H, Spivak CE, Xiao Y, Kellar K, Ravert HT, Kumar A, Alexander M, Hilton J, Wong DF, Dannals RF, Horti AG.
    J Med Chem; 2008 Aug 14; 51(15):4751-64. PubMed ID: 18605717
    [Abstract] [Full Text] [Related]

  • 6. The Relationship of Varenicline Agonism of α4β2 Nicotinic Acetylcholine Receptors and Nicotine-Induced Dopamine Release in Nicotine-Dependent Humans.
    McCaul ME, Wand GS, Kuwabara H, Dannals RF, Wong D, Xu X.
    Nicotine Tob Res; 2020 May 26; 22(6):892-899. PubMed ID: 31096265
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.
    Bois F, Gallezot JD, Zheng MQ, Lin SF, Esterlis I, Cosgrove KP, Carson RE, Huang Y.
    Nucl Med Biol; 2015 Jun 26; 42(6):570-7. PubMed ID: 25858513
    [Abstract] [Full Text] [Related]

  • 8. Recent PET radioligands with optimal brain kinetics for imaging nicotinic acetylcholine receptors.
    Horti AG, Kuwabara H, Holt DP, Dannals RF, Wong DF.
    J Labelled Comp Radiopharm; 2013 Jun 26; 56(3-4):159-66. PubMed ID: 24285321
    [Abstract] [Full Text] [Related]

  • 9. 18F-ZW-104: a new radioligand for imaging neuronal nicotinic acetylcholine receptors--in vitro binding properties and PET studies in baboons.
    Valette H, Xiao Y, Peyronneau MA, Damont A, Kozikowski AP, Wei ZL, Kassiou M, Kellar KJ, Dollé F, Bottlaender M.
    J Nucl Med; 2009 Aug 26; 50(8):1349-55. PubMed ID: 19652217
    [Abstract] [Full Text] [Related]

  • 10. 11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurements.
    Ettrup A, Mikkelsen JD, Lehel S, Madsen J, Nielsen EØ, Palner M, Timmermann DB, Peters D, Knudsen GM.
    J Nucl Med; 2011 Sep 26; 52(9):1449-56. PubMed ID: 21828113
    [Abstract] [Full Text] [Related]

  • 11. Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epibatidine analog.
    Villemagne VL, Horti A, Scheffel U, Ravert HT, Finley P, Clough DJ, London ED, Wagner HN, Dannals RF.
    J Nucl Med; 1997 Nov 26; 38(11):1737-41. PubMed ID: 9374343
    [Abstract] [Full Text] [Related]

  • 12. Specific α4β2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkey.
    Hillmer AT, Wooten DW, Moirano JM, Slesarev M, Barnhart TE, Engle JW, Nickles RJ, Murali D, Schneider ML, Mukherjee J, Christian BT.
    Synapse; 2011 Dec 26; 65(12):1309-18. PubMed ID: 21674627
    [Abstract] [Full Text] [Related]

  • 13. PET imaging of α4β2* nicotinic acetylcholine receptors: quantitative analysis of 18F-nifene kinetics in the nonhuman primate.
    Hillmer AT, Wooten DW, Slesarev MS, Ahlers EO, Barnhart TE, Murali D, Schneider ML, Mukherjee J, Christian BT.
    J Nucl Med; 2012 Sep 26; 53(9):1471-80. PubMed ID: 22851633
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
    Chattopadhyay S, Xue B, Collins D, Pichika R, Bagnera R, Leslie FM, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J.
    J Nucl Med; 2005 Jan 26; 46(1):130-40. PubMed ID: 15632043
    [Abstract] [Full Text] [Related]

  • 15. A single administration of low-dose varenicline saturates α4β2* nicotinic acetylcholine receptors in the human brain.
    Lotfipour S, Mandelkern M, Alvarez-Estrada M, Brody AL.
    Neuropsychopharmacology; 2012 Jun 26; 37(7):1738-48. PubMed ID: 22395733
    [Abstract] [Full Text] [Related]

  • 16. Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380.
    Le Foll B, Chefer SI, Kimes AS, Shumway D, Goldberg SR, Stein EA, Mukhin AG.
    J Nucl Med; 2007 Sep 26; 48(9):1492-500. PubMed ID: 17704243
    [Abstract] [Full Text] [Related]

  • 17. 18F-XTRA PET for Enhanced Imaging of the Extrathalamic α4β2 Nicotinic Acetylcholine Receptor.
    Coughlin JM, Slania S, Du Y, Rosenthal HB, Lesniak WG, Minn I, Smith GS, Dannals RF, Kuwabara H, Wong DF, Wang Y, Horti AG, Pomper MG.
    J Nucl Med; 2018 Oct 26; 59(10):1603-1608. PubMed ID: 29496987
    [Abstract] [Full Text] [Related]

  • 18. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.
    Paterson NE, Min W, Hackett A, Lowe D, Hanania T, Caldarone B, Ghavami A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec 01; 34(8):1455-64. PubMed ID: 20708056
    [Abstract] [Full Text] [Related]

  • 19. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates.
    Hillmer AT, Zheng MQ, Li S, Scheunemann M, Lin SF, Holden D, Labaree D, Ropchan J, Teodoro R, Deuther-Conrad W, Carson RE, Brust P, Huang Y.
    Eur J Nucl Med Mol Imaging; 2016 Mar 01; 43(3):537-47. PubMed ID: 26455500
    [Abstract] [Full Text] [Related]

  • 20. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
    Varrone A, Stepanov V, Nakao R, Tóth M, Gulyás B, Emond P, Deloye JB, Vercouillie J, Stabin MG, Jonsson C, Guilloteau D, Halldin C.
    J Nucl Med; 2011 Aug 01; 52(8):1313-21. PubMed ID: 21764797
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.